<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Microvesicles (MVs) are released by various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, including <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="1" pm="."><plain>They can "hijack" membrane components from their parental cells and exert pleiotropic effects on <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Human <z:chebi fb="91" ids="25698">ether</z:chebi>-a-go-go-related gene (hERG1) <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels are highly expressed in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells and appear of exceptional importance in favoring <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
<SENT sid="3" pm="."><plain>Given the attributes of MVs and hERG1 <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels in disease progression, we investigated the putative relationship between hERG1 <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels and MVs in <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The protein content of MVs isolated from K562 cell supernatants was significantly higher than that from <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells </plain></SENT>
<SENT sid="5" pm="."><plain>The molecular profile of these MVs showed that in addition to the myeloid lineage antigen (CD11b), MVs contained hERG1 <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, inhibition of hERG1 <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels rapidly reduced MV fractions in supernatants </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, MVs created positive feedback loops to facilitate <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Upon exposure to MVs, the plasma membrane expression of hERG1 protein was in turn up-regulated, the migration of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells was significantly increased, and the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells to human umbilical vein endothelial cells (HUVECs) was markedly enhanced </plain></SENT>
<SENT sid="9" pm="."><plain>Importantly, hERG1 <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel inhibitor E-4031 impaired these effects </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell-derived MVs can "hijack" the plasma membrane hERG1 <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels, which regulate the release of MVs and their biological effects upon <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
</text></document>